Uncategorized
John Doux, MD
JOHN DOUX, MD ANALYSTPALO ALTO INVESTORS John Doux has been an analyst at Palo Alto Investors since 2004. He currently serves as a board director of Lutris Pharma, and served previously as board chair of ValenzaBio (acquired by ACELYRIN), and as a board director of Ceptaris Therapeutics (acquired by Actelion Pharmaceuticals) and Palvella Therapeutics. A board certified…
Read MoreCaro Van Hove
Caroline (Caro) Van Hove is a global commercial leader with over 20 years of diverse experience in the pharmaceutical, consumer and medical device industry. Her experience spans North America to Europe, Africa, the Middle East to Asia Pacific and Latin America. Ms. Van Hove is currently President and CEO of Revelle Aesthetics, a venture-backed, medical…
Read MoreRyan Irvine, PhD
Ryan Irvine joined Hugel in November 2021 as Vice President, Medical Affairs. He is an accomplished scientist and corporate executive working across technical fields for more than 15 years. In biotechnology, Dr. Irvine has accumulated direct and meaningful experience in medical communications, nonclinical and clinical development, regulatory strategy, commercialization, and product launch. He has held…
Read MorePatrick Urban
Alan D. Widgerow, MBBCh, MMed, FCS, FACS
Investors
INVESTORS High Net Worth Individuals/angels Venture Capitalists Private Equity/Buyout Investors Corporate/Strategic Investors Investment & Commercial Bankers Stock Analysts Institutional Investors/Fund Managers
Read MoreThomas Shaffer
Juliet Bakker
Ms. Bakker is a Managing Director and Founder of Longitude Capital. Prior to Longitude Capital, Ms. Bakker was a Managing Director of Pequot Ventures where she founded the life sciences investment practice. Previously, she was Director, Strategic Planning and Director, Operations of Waste Management International. Previously, she was a sell-side equity analyst with Banque Paribas.…
Read MorePodcast Title Here
Dr. Rowland’s professional interests are at the intersection of transformative technologies and emerging business opportunities. He has been active in research and development of micro and nanotechnology fabrication methods for 15 years, including invited research at Sandia National Laboratories, New Mexico and Trinity College, Ireland. Dr. Rowland has authored or presented over 15 conference and…
Read MoreHans Keirstead, PhD
Dr. Keirstead is an internationally known stem cell expert and has led therapy development for late stage cancers, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. He is the CEO of AIVITA Biomedical. He was previously CSO of Caladrius which acquired California Stem Cell in 2014. Dr. Keirstead founded California Stem Cell,…
Read More